Insiders Updates Recent Insider Activity Could Benefit X4 Pharmaceuticals Inc (XFOR) In a filing, X4 Pharmaceuticals Inc revealed its Chief Commercial Officer Baldry Mark acquired Company’s shares for reported $2561.0 on
X4 Pharmaceuticals Inc. (NASDAQ: XFOR) Gets A 80.4% Target Price Upside From Analysts While 50.75% Above Its 52-Week Low X4 Pharmaceuticals Inc. (NASDAQ:XFOR) does about 1.33M shares in volume on a normal day but saw 423127 shares change hands